Takeda seeks gov't OK to distribute Moderna COVID vaccine in Japan

Takeda Pharmaceutical Co. said Friday it has filed a request with Japan's health ministry for the approval of U.S. biotechnology company Moderna Inc.'s COVID-19 vaccine in the country.It is the third application for regulatory approval of a COVID-19 vaccine in Japan, following U.S. pharmaceutical giant Pfizer Inc. and Britain's AstraZeneca Plc.Takeda is Moderna's partner for the clinical study, importation and distribution of the vaccine in Japan.Under an agreement with the Japanese government, Takeda plans to supply 50 million doses of the Moderna vaccine, enough for 25 million people.The …READ FULL ARTICLE